Elixinol Global Ltd. engages in the sale of nutraceutical and related hemp products. It manufactures and distributes industrial hemp products and early stage medical cannabis business focusing on the importation, cultivation, manufacture and distribution of CBD and THC products. The firm operates through the following segments: The company was founded by Paul Benhaim on September 4, 2017 and is headquartered in Sydney, Australia.
No Data
No Data